About this Research Topic
The intersection of virus detection and antiviral drug development is a critical area of research, especially in the context of emerging viral diseases. The current landscape is marked by the need for rapid identification and response to viral threats, which is facilitated by advanced epidemiological surveillance systems. These systems are crucial for the early detection of new viral strains, allowing for timely intervention strategies that can significantly alter the course of potential outbreaks. Recent studies have shown progress in both virus detection technologies and antiviral drug development, yet challenges such as drug resistance, limited efficacy, and safety concerns persist. Despite these advancements, there remains a gap in comprehensive strategies that integrate detection and treatment, particularly for zoonotic infections that cross from animals to humans. Addressing these gaps is essential for strengthening our defenses against viral threats and ensuring effective management of viral diseases across diverse populations.
This research topic aims to catalyze innovation in the fight against emerging viral diseases by encouraging submissions that cover original research, reviews, and perspectives. The focus spans the epidemiology, detection methods, and development of antiviral drugs for human and animal viral diseases, with a particular emphasis on zoonotic diseases. The goal is to foster collaboration and knowledge exchange among scientists to accelerate progress in viral disease detection and drug treatment, addressing critical challenges such as drug resistance and safety concerns. By understanding the genetic variations and evolutionary patterns of these viruses, researchers can devise effective strategies to curb their spread and mitigate their impact on public health.
To gather further insights in the detection and drug treatment of emerging viral diseases, we welcome articles addressing, but not limited to, the following themes:
- Establishment of epidemiological investigations and detection methods for human and animal viruses, pet viruses, and zoonotic pathogens.
- Molecular tracing and genetic variation analysis.
- Study of codon usage bias in human and animal viral genomes.
- Screening of antiviral drugs and research on their mechanisms of action.
- Investigation of traditional Chinese medicine applications in antiviral therapies for zoonotic diseases.
This research topic aims to catalyze innovation in the fight against emerging viral diseases by encouraging submissions that cover original research, reviews, and perspectives. The focus spans the epidemiology, detection methods, and development of antiviral drugs for human and animal viral diseases, with a particular emphasis on zoonotic diseases. The goal is to foster collaboration and knowledge exchange among scientists to accelerate progress in viral disease detection and drug treatment, addressing critical challenges such as drug resistance and safety concerns. By understanding the genetic variations and evolutionary patterns of these viruses, researchers can devise effective strategies to curb their spread and mitigate their impact on public health.
To gather further insights in the detection and drug treatment of emerging viral diseases, we welcome articles addressing, but not limited to, the following themes:
- Establishment of epidemiological investigations and detection methods for human and animal viruses, pet viruses, and zoonotic pathogens.
- Molecular tracing and genetic variation analysis.
- Study of codon usage bias in human and animal viral genomes.
- Screening of antiviral drugs and research on their mechanisms of action.
- Investigation of traditional Chinese medicine applications in antiviral therapies for zoonotic diseases.
Keywords: cross species infection, antiviral drugs, zoonotic diseases, genetic evolution, molecular epidemiology
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
